Maven Clinic secures US$90m to advance reproductive health platform

The US virtual clinic Maven has raised US$90m in funding to invest in personalisation across its reproductive health platform.

The end-to-end reproductive health and family care platform offers support and virtual care, including fertility, family building, maternity, parenting, pediatrics and menopause support.

The clinic partners with employers and health plans to deliver family benefit design in an effort to reduce costs of care and improve clinical outcomes.

The new funding round, led by General Catalyst, with participation from CVS Health Ventures, La Famiglia and Intermountain Ventures, will bring Maven’s total funding to US$300m, highlighting the growing demand for women’s and family health services globally.

“At Maven, we have reimagined the care model to address the complex needs of women and families in a global system that was not designed for them,” said Kate Ryder, founder and CEO of Maven Clinic.

“Whether it’s a pregnant woman faced with access issues in rural America, working parents in India needing financial support and navigation for infertility treatment, a same-sex couple facing bias in the opaque surrogacy industry, or a senior executive unable to get support for menopause, our platform shows up reliably, affordably, and relentlessly focused on patient outcomes.”

The clinic says it will use the capital to invest in personalisation across its platform to drive meaningful outcomes in both commercial and Medicaid populations, enhance localisation of resources to meet the cultural and country-specific needs of its members, and increase depth of support across all family and reproductive health life stages.

With almost one third of US women of reproductive age living in states with restrictions on access to abortion, 15 per cent of reproductive-age couples globally experiencing infertility, and nearly one in three women saying they have taken sick days for their menopause symptoms, the need for greater access to quality care has become even more urgent.

Dr Jeff Tzeng, AT&T senior vice president of health and wellbeing, said: “At AT&T, we’re passionate about providing world-class, family-focused benefits to support the total wellbeing of our employees.

“Maven is a wonderful complement to the generous reproductive health benefits, paid parental leave and family planning resources we offer, helping AT&T mums and dads access care providers, educational materials and parental support at every stage of their experience.

Holly Maloney, managing director at General Catalyst, added: “Maven’s technology-driven platform is purpose-built to create a personalised care experience for all women and families regardless of geography, income level, or pathway to parenthood,  which aligns with our health assurance mission to create a proactive and equitable system of care.

“Maven has already demonstrated incredible outcomes driving commercial traction and a breadth of coverage that we have not seen in a women’s and family care platform.

“The GC health assurance team and community is excited to join Maven in this exciting new phase of growth.”